Division of Nephrology and Hypertension

September 11, 2017

Vanderbilt, Bayer collaborate to develop new therapies against kidney diseases

Vanderbilt University Medical Center (VUMC) and Bayer have agreed on a five-year strategic research alliance to evaluate new drug candidates for the treatment of kidney diseases, with the goal of accelerating the translation of innovative approaches from the laboratory to pre-clinical development.

By VUMC News and Communications
August 31, 2017

End-stage kidney disease study seeks to delay dialysis

Vanderbilt University Medical Center (VUMC) is studying the safety of a possible treatment for diabetic kidney disease that would delay or prevent the need for kidney replacement such as dialysis.

By Kathy Whitney
Insulin in vials
May 11, 2017

EETs contribute to insulin sensitivity

Interventions that increase circulating levels of compounds called EETs may improve insulin sensitivity and treat hypertension.

By Leigh MacMillan
November 21, 2016

Building the basement membrane

Vanderbilt researchers have discovered steps in the regulation of a key enzyme that builds the basement membrane, a structure that undergirds nearly all animal tissues.

By Bill Snyder
August 30, 2016

VUMC mourns loss of Nephrology’s Schulman

Gerald Schulman, M.D., professor of Medicine, died Aug. 26. He was 65.

By Kathy Whitney
November 12, 2015

Harris to lead American Society of Nephrology

Ray Harris, M.D., has been elected president of the American Society of Nephrology during the society’s annual meeting, ASN Kidney Week 2015, in San Diego.

By Kathy Whitney
October 29, 2015

Inflammation, obesity and diabetes

Vanderbilt study adds to the mounting role for inflammatory signaling in obesity.
By Leigh MacMillan
September 17, 2015

Study shows lower systolic BP targets reduce death risk

The initial results of a landmark clinical trial sponsored by the National Institutes of Health (NIH) indicate lowering systolic blood pressure below a commonly recommended target significantly reduces rates of cardiovascular events and lowers risk of death in a group of adults 50 years and older.
By Kathy Whitney
1 2 3